{"podcast":{"title":"Cell & Gene: The Podcast","slug":"cell-gene-the-podcast-4048431","podcast_index_feed_id":4048431,"rss_url":"https://rss.buzzsprout.com/1810482.rss","website_url":"https://www.buzzsprout.com/1810482","image_url":"https://storage.buzzsprout.com/f3p8rfd9kizh4zywm5msg5goq7nu?.jpg","author":"Erin Harris","episode_count":143,"summary":"Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.","last_synced_at":"2026-07-30T18:18:21.970469+00:00","page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431"},"episode":{"title":"How Precision Oncology Is Redefining Cancer Drug Development with Aprea Therapeutics' Dr. Oren Gilad","slug":"how-precision-oncology-is-redefining-cancer-drug-development-with-aprea-therapeutics-dr-oren-gilad","published_at":"2026-07-16T09:00:00+00:00","page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431/how-precision-oncology-is-redefining-cancer-drug-development-with-aprea-therapeutics-dr-oren-gilad","show_page_url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431","url":"https://www.buzzsprout.com/1810482/episodes/19487695-how-precision-oncology-is-redefining-cancer-drug-development-with-aprea-therapeutics-dr-oren-gilad.mp3","audio_url":"https://www.buzzsprout.com/1810482/episodes/19487695-how-precision-oncology-is-redefining-cancer-drug-development-with-aprea-therapeutics-dr-oren-gilad.mp3","summary":"We love to hear from our listeners. Send us a message. Episode 133 of Cell & Gene: The Podcast features Host Erin Harris' discussion with Aprea Therapeutics' CEO, Dr. Oren Gilad. They cover the evolution of precision oncology, the science of synthetic lethality, and how Aprea is developing next-generation therapies that target cancer's unique genetic vulnerabilities while improving safety and efficacy. Dr. Gilad also shares insights into biomarker-driven drug development, where precision ...","meta_description":"We love to hear from our listeners. Send us a message. Episode 133 of Cell & Gene: The Podcast features Host Erin Harris' discussion with Aprea Therap…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1083,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/how-precision-oncology-is-redefining-cancer-drug-development-with-aprea-therapeutics-dr-oren-gilad/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/cell-gene-the-podcast-4048431/how-precision-oncology-is-redefining-cancer-drug-development-with-aprea-therapeutics-dr-oren-gilad.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}